Li Ding
Impact in
-
- Diabetes Treatment and Management
- Natural Antidiabetic Agents Studies
Papers in
-
- Advanced Sensor and Energy Harvesting Materials 5
- Microfluidic and Capillary Electrophoresis Applications 3
- Innovative Microfluidic and Catalytic Techniques Innovation 3
- Co-authors
- Zhang Jin (1 shared paper)Daozhong Jin (1 shared paper)Xiaoli Chen (1 shared paper)Xingyu Jiang (8 shared papers)Jie Qi (6 shared papers)Hang Chen (5 shared papers)Ruihua Dong (4 shared papers)Honglong Chang (5 shared papers)
- Journals
- Sensors and Actuators B Chemical (4 papers)Nano Letters (2 papers)Journal of Ethnopharmacology (2 papers)Frontiers in Pharmacology (2 papers)Diabetologia (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Li Ding
45 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 122
- Biological Psychiatry 25
- Endocrinology, Diabetes and Metabolism 141
- Biomedical Engineering 365
- Polymers and Plastics 97
- Cellular and Molecular Neuroscience 111
Countries citing papers authored by Li Ding
This map shows the geographic impact of Li Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Ding more than expected).
Fields of papers citing papers by Li Ding
This network shows the impact of papers produced by Li Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Ding. The network helps show where Li Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 132 | |
| 2 | 2011 | 125 | |
| 3 | 2023 | 108 | |
| 4 | 2020 | 84 | |
| 5 | 2022 | 78 | |
| 6 | 2019 | 53 | |
| 7 | 2017 | 42 | |
| 8 | 2021 | 39 | |
| 9 | 2021 | 37 | |
| 10 | 2020 | 31 | |
| 11 | 2016 | 30 | |
| 12 | 2021 | 26 | |
| 13 | 2022 | 25 | |
| 14 | 2018 | 24 | |
| 15 | 2019 | 23 | |
| 16 | 2024 | 22 | |
| 17 | 2010 | 19 | |
| 18 | 2014 | 16 | |
| 19 | Ginsenoside Rb1 increases insulin sensitivity through suppressing 11β-hydroxysteroid dehydrogenase type I. | 2017 | 15 |
| 20 | 2019 | 15 |
About Li Ding
Li Ding is a scholar working on Biomedical Engineering, Molecular Biology, Cellular and Molecular Neuroscience, Endocrinology, Diabetes and Metabolism and Electrical and Electronic Engineering, having authored 47 papers that have together received 1.1k indexed citations. Recurring topics across this work include Advanced Sensor and Energy Harvesting Materials (5 papers), Neuroscience and Neural Engineering (4 papers), Microfluidic and Capillary Electrophoresis Applications (3 papers), Innovative Microfluidic and Catalytic Techniques Innovation (3 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers), Hormonal Regulation and Hypertension (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and Electrospun Nanofibers in Biomedical Applications (2 papers). The work is most often cited by research in Biological Psychiatry (25 citations), Endocrinology, Diabetes and Metabolism (141 citations), Biomedical Engineering (365 citations), Polymers and Plastics (97 citations) and Cellular and Molecular Neuroscience (111 citations). Li Ding has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Zhang Jin, Daozhong Jin, Xiaoli Chen, Xingyu Jiang, Jie Qi, Hang Chen, Ruihua Dong, Honglong Chang, Shuaijian Yang and Shiyu Cheng. Their work appears in journals such as Sensors and Actuators B Chemical, Nano Letters, Journal of Ethnopharmacology, Frontiers in Pharmacology and Diabetologia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.